Medicare’s recent decision to cover Novo Nordisk A/S’s blockbuster obesity shot Wegovy for heart disease will possibly subsidize the drug for some 3.6 million people, according to a new study from Kaiser Family Foundation.
Wegovy Access Expands to Millions in US on Medicare, Study FindsAirlines Must Now Pay Automatic Refunds for Canceled FlightsUBS Chairman Says He’s Seriously Concerned Over Capital ReformsCocoa Price Swings Are the Craziest Since the 1970sFrench Grid Issues Are Causing Power Prices to Soar in EuropeASML CEO Wennink’s Exit Leaves US-China Semiconductor Fight to SuccessorTesla to Accelerate Launch of Cheaper Cars After Sales MissUBS Chairman Says He’s Seriously Concerned Over Capital ReformsFrench...
Corruption ProbeCVC and Puig Debuts Set to Test Strength of Europe’s IPO ReboundIn Jammu, Modi Seeks Approval for Scrapping Kashmir Autonomy: India VotesSome LDP Members Oppose BOJ Rate Hikes Ahead of Political EventsSenate Sends Aid Package With Iran Oil Sanctions to BidenASML CEO Wennink’s Exit Leaves US-China Semiconductor Fight to SuccessorUS Regulator Seeks $5.
Philippines Latest News, Philippines Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Novo ready to seek German insurance coverage of Wegovy for heart useExplore stories from Atlantic Canada.
Read more »
Novo ready to seek German insurance coverage of Wegovy for heart useExplore stories from Atlantic Canada.
Read more »
India's Biocon developing its own version of Wegovy, clinical trial likely next yearExplore stories from Atlantic Canada.
Read more »
India's Biocon developing its own version of Wegovy, clinical trial likely next yearExplore stories from Atlantic Canada.
Read more »
No link between Ozempic, Wegovy and suicide, EU drug regulators sayDrug regulators in Europe have found no evidence that popular diabetes and weight-loss drugs like Ozempic and Wegovy are linked to a higher risk of suicidal ...
Read more »
EU Probe Finds No Added Suicide Risk Linked to Novo’s WegovyThe European Union’s drug regulator found no added risk of suicide or self-harm for people taking a popular new class of weight-loss and diabetes medicines that includes Novo Nordisk A/S’s Wegovy and Ozempic.
Read more »